Hemotune
Founded 2017 · 32 employees on LinkedIn · 6 known investors
Find your way into Hemotune
Sign up to find every way you can get introduced to Hemotune
- Your email: who you already know at Hemotune, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Hemotune team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medical and biomanufacturing applications. The platform removes disease triggers and harmful agents from the bloodstream or processes biological materials with high selectivity and scalability.
Investors · 6
How we know: funding news · hemotune.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries B2Mar 2024 · 2 sources
Belmondo (lead), EFI, HEMEX, OCCIDENT, VP Venture Partners, ZKB
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Hemotune went on to found or lead other companies.
Frequently asked questions
- What does Hemotune do?
- hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medical and biomanufacturing applications. The platform removes disease triggers and harmful agents from the bloodstream or processes biological materials with high selectivity and scalability.
- Who are Hemotune's investors?
- Hemotune's investors include OCCIDENT.



